logo-loader
viewCello Health PLC

Cello Group hails the impact of a “vibrant” US on the company’s performance

Chief executive of Cello Group (LON:CLL) Mark Scott spoke to Proactive’s Charlotte Kan in the wake of an upbeat trading update from healthcare and strategic consumer marketing specialist.
The research and communications operations both performed well, but there was a common theme to update – the United States.
“The overall exposure we have is to the US,” Scott explained.
“Around half of our business is US business and the US generally speaking, and healthcare in particular, is more vibrant than Europe, for sure. US exposure is pretty key to our growth.”
He said the Cello Health arm came together as a single business around two-and-a-half years ago and has benefited from it.
Scott pointed out Cello Signal is following the same path, with similar results: “It is coming together as a single client proposition… We are accessing bigger contract opportunities and winning our fair share of them.”

Quick facts: Cello Health PLC

Price: 133.425 GBX

AIM:CLL
Market: AIM
Market Cap: £141.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19

RNS

Total Voting Rights

1 week, 6 days ago

Holding(s) in Company

3 weeks, 3 days ago

Holding(s) in Company

on 14/11/19

Total Voting Rights

on 13/11/19

Total Voting Rights

on 7/10/19

Disposal

on 2/10/19

Interim Results

on 18/9/19

2 min read